
About


Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope

The EU member states’ votes banning a product cannot be presumed confidential: Why we litigated Case T-201/21 Covington & VanVooren vs European Commission (and won)

Historic Marine Biodiversity Treaty creates new Access and Benefit-Sharing obligations for life sciences companies

EU Pharma Legislation Review Series: GMO Medicines

EU Pharma Legislation Review Series: Addressing Environmental Risks

Green Groceries: Key ESG Issues for the FMCG Industry (including FBOs)
Green Groceries: Key ESG Issues for the FMCG Industry (including FBOs)
Submit your views! Consultation on the New Global Biodiversity Fund Paid For by Life Sciences Companies that “Use Digital Sequence Information on Genetic Resources”
